XML 65 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727
OPERATING SEGMENT AND GEOGRAPHIC INFORMATION
 6 Months Ended
Jun. 30, 2015
Segment Reporting [Abstract]  
Operating Segment and Geographic Information
OPERATING SEGMENT AND GEOGRAPHIC INFORMATION
Our chief operating decision-maker is our Chief Executive Officer, who regularly evaluates our performance based on net sales and net loss before taxes. The preparation of this segment analysis requires management to make estimates and assumptions around expenses below the gross profit level. While we believe the segment information to be directionally correct, actual results could differ from the estimates and assumptions used in preparing this information.
We have two reportable operating segments, Laboratory Services and Genetic Assays and Platforms.
 
Segment information for the three months ended June 30, 2015 and 2014 was as follows: 
 
Dollars in Thousands
 
Three Months Ended June 30, 2015
 
Laboratory Services
 
Genetic Assays
and Platforms
 
Total
Net Sales
$
4,839

 
$
2,201

 
$
7,040

Gross Profit
2,634

 
238

 
2,872

Net Loss before Taxes
(2,167
)
 
(1,066
)
 
(3,233
)
Income Tax Expense
40

 
2

 
42

Net Loss
$
(2,207
)
 
$
(1,068
)
 
$
(3,275
)
Depreciation/Amortization
$
517

 
$
41

 
$
558

Interest Expense, net
$
131

 
$
55

 
$
186

 
 
 
 
 
 
 
June 30, 2015
Total Assets
$
25,870

 
$
5,539

 
$
31,409


 
 
 
 
 
 
 
Dollars in Thousands
 
Three Months Ended June 30, 2014
 
Laboratory Services
 
Genetic Assays
and Platforms
 
Total
Net Sales
$
3,843

 
$
2,921

 
$
6,764

Gross Profit
1,490

 
903

 
2,393

Net Loss before Taxes
(3,277
)
 
(624
)
 
(3,901
)
Income Tax Expense (Benefit)
40

 
(48
)
 
(8
)
Net Loss
$
(3,317
)
 
$
(576
)
 
$
(3,893
)
Depreciation/Amortization
$
438

 
$
50

 
$
488

Interest Expense, net
$
83

 
$
63

 
$
146

 
 
 
 
 
 
 
June 30, 2014
Total Assets
$
23,370

 
$
7,721

 
$
31,091


Segment information for the six months ended June 30, 2015 and 2014 is as follows:

 
Dollars in Thousands
 
Six Months Ended June 30, 2015
 
Laboratory Services
 
Genetic Assays
and Platforms
 
Total
Net Sales
$
9,710

 
$
3,843

 
$
13,553

Gross Profit
5,330

 
516

 
5,846

Net Loss before Taxes
(4,277
)
 
(1,951
)
 
(6,228
)
Income Tax Expense
81

 
7

 
88

Net Loss
$
(4,358
)
 
$
(1,958
)
 
$
(6,316
)
Depreciation/Amortization
$
1,024

 
$
87

 
$
1,111

Interest Expense, net
$
273

 
$
103

 
$
376

 
 
 
 
 
 


 
 
 
 
 
 
 
Dollars in Thousands
 
Six Months Ended June 30, 2014
 
Laboratory Services
 
Genetic Assays
and Platforms
 
Total
Net Sales
$
7,531

 
$
5,484

 
$
13,015

Gross Profit
3,122

 
1,765

 
4,887

Net Loss before Taxes
(6,261
)
 
(1,311
)
 
(7,572
)
Income Tax Expense (Benefit)
549

 
(52
)
 
497

Net Loss
$
(6,810
)
 
$
(1,259
)
 
$
(8,069
)
Depreciation/Amortization
$
878

 
$
103

 
$
981

Interest Expense, net
$
190

 
$
138

 
$
328

 
 
 
 
 
 


Net sales for the three and six months ended June 30, 2015 and 2014 by country were as follows:
 
 
Dollars in Thousands
 
Dollars in Thousands
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2015
 
2014
 
2015
 
2014
United States
$
5,897

 
$
4,870

 
$
11,405

 
$
9,633

Italy
193

 
337

 
370

 
722

All Other Countries
950

 
1,557

 
1,778

 
2,660

Total
$
7,040

 
$
6,764

 
$
13,553

 
$
13,015


Other than the countries specifically identified above, no country individually accounted for more than 5% of total net sales.

Approximately 99% of our long-lived assets are located within the United States.